PHAXIAM Therapeutics S.A.
PHXM
Ранг среди акций
#39391
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Цена акции
$0.11725176
Последняя синхронизация: 2025-07-14
Рыночная капитализация
$481.50K
Изменение (1 день)
-0.20%
Изменение (1 год)
-1.64%
Страна
FR
Торговля PHAXIAM Therapeutics S.A. (PHXM)
Категория
Healthcare
История дроблений акций PHAXIAM Therapeutics S.A. (PHXM)
Акции PHAXIAM Therapeutics S.A. (символ: PHXM) прошли через 0 дроблений.
Последнее дробление произошло Oct 21, 2026.
Одна акция PHXM, купленная до Oct 21, 2026, сейчас соответствует 0 акциям PHXM.
Последнее дробление произошло Oct 21, 2026.
Одна акция PHXM, купленная до Oct 21, 2026, сейчас соответствует 0 акциям PHXM.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
